TECH Bio-Techne
Bio-Techne earnings company data as of 7:06 PM ET 10/30
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 4 Nov | EPS | 0.40 | — | — |
| Rev | $292.2M | — | — |
Insider trades
Open-market buys and sales by TECH's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $437K sold by 1 insider outside a trading plan
- None no planned (10b5-1) sales
-
Amy E. Herr DirectorSale$320K 6,636 shares at $48.28 97% of stakeTraded May 8 Filed May 12
-
Amy E. Herr DirectorSale$117K 1,976 shares at $59.11 91% of stakeTraded Feb 17 Filed Feb 19
Also filed in the last 12 months, not counted as buying or selling: 26 option exercises and 25 share withholdings for taxes.
SEC filings
Recent issuer filings from EDGAR, 17 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 10-K/A | Filing Doc | ||
| 8-K | 5.07,7.01,9.01 | Filing Doc | |
| 8-K | 8.01 | Filing Doc | |
| DEFA14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| 10-K | Filing Doc | ||
| 8-K | 2.02,8.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| DEFA14A | SOLICITING MATERIAL | Filing Doc | |
| 8-K | 1.01,5.02,9.01 | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| DEFA14A | SOLICITING MATERIAL | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 2.02,8.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.